Simplex Trading’s Adverum Biotechnologies ADVM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-4,313
| Closed | -$12.1K | – | 8502 |
|
|
2025
Q1 | $18K | Buy |
4,313
+2,319
| +116% | +$10.5K | ﹤0.01% | 6636 |
|
|
2024
Q4 | $9K | Buy |
+1,994
| New | +$13.4K | ﹤0.01% | 7234 |
|
|
2024
Q3 | – | Sell |
-322
| Closed | -$2.34K | – | 8350 |
|
|
2024
Q2 | $2K | Buy |
+322
| New | +$2.99K | ﹤0.01% | 8206 |
|
|
2024
Q1 | – | Sell |
-233
| Closed | -$3.54K | – | 8730 |
|
|
2023
Q4 | $1K | Buy |
+233
| New | +$2.13K | ﹤0.01% | 8420 |
|
|
2021
Q4 | – | Sell |
-3,443
| Closed | -$68.9K | – | 10362 |
|
|
2021
Q3 | $123K | Hold |
3,443
| – | – | ﹤0.01% | 6319 |
|
|
2021
Q2 | $120K | Buy |
3,443
+2,493
| +262% | +$134K | ﹤0.01% | 6459 |
|
|
2021
Q1 | $93K | Buy |
950
+440
| +86% | +$52.8K | ﹤0.01% | 5843 |
|
|
2020
Q4 | $55K | Sell |
510
-2,193
| -81% | -$271K | ﹤0.01% | 6066 |
|
|
2020
Q3 | $278K | Sell |
2,703
-5,819
| -68% | -$871K | ﹤0.01% | 3687 |
|
|
2020
Q2 | $1.78M | Buy |
8,522
+7,292
| +593% | +$1.29M | ﹤0.01% | 1604 |
|
|
2020
Q1 | $120K | Sell |
1,230
-2,816
| -70% | -$328K | ﹤0.01% | 4169 |
|
|
2019
Q4 | $466K | Buy |
+4,046
| New | +$357K | ﹤0.01% | 2809 |
|
|
2019
Q3 | – | Sell |
-2,130
| Closed | -$240K | – | 7164 |
|
|
2019
Q2 | $253K | Buy |
2,130
+1,983
| +1,349% | +$164K | ﹤0.01% | 3236 |
|
|
2019
Q1 | $7K | Sell |
147
-472
| -76% | -$19.1K | ﹤0.01% | 6316 |
|
|
2018
Q4 | $19K | Buy |
619
+32
| +5% | +$1.3K | ﹤0.01% | 5351 |
|
|
2018
Q3 | $35K | Buy |
+587
| New | +$33K | ﹤0.01% | 5497 |
|
|
2018
Q2 | – | Sell |
-3,993
| Closed | -$240K | – | 7293 |
|
|
2018
Q1 | $231K | Buy |
3,993
+1,102
| +38% | +$68.6K | 0.01% | 1146 |
|
|
2017
Q4 | $101K | Buy |
2,891
+1,313
| +83% | +$43.2K | ﹤0.01% | 1795 |
|
|
2017
Q3 | $57K | Buy |
1,578
+1,562
| +9,763% | +$43.3K | ﹤0.01% | 2182 |
|
|
2017
Q2 | $0 | Buy |
+16
| New | +$438 | ﹤0.01% | 5981 |
|
|
2017
Q1 | – | Sell |
-61
| Closed | -$1K | – | 6057 |
|
|
2016
Q4 | $1K | Sell |
61
-285
| -82% | -$9.31K | ﹤0.01% | 5286 |
|
|
2016
Q3 | $14K | Sell |
346
-832
| -71% | -$31.6K | ﹤0.01% | 3295 |
|
|
2016
Q2 | $37K | Buy |
1,178
+792
| +205% | +$35.8K | ﹤0.01% | 2332 |
|
|
2016
Q1 | $19K | Buy |
+386
| New | +$21.6K | ﹤0.01% | 2836 |
|
|
2015
Q4 | – | Sell |
-1,781
| Closed | -$156K | – | 5295 |
|
|
2015
Q3 | $146K | Sell |
1,781
-2,172
| -55% | -$277K | 0.01% | 1117 |
|
|
2015
Q2 | $641K | Buy |
3,953
+2,661
| +206% | +$898K | 0.05% | 330 |
|
|
2015
Q1 | $523K | Buy |
+1,292
| New | +$546K | 0.06% | 320 |
|
Simplex Trading's ADVM Position: Q2 2025 in Review
Simplex Trading sold out of Adverum Biotechnologies (ADVM) in Q2 2025, closing a stake of 4,313 shares — an estimated $12.1K sold.
Simplex Trading first reported a position in ADVM in Q1 2015 and held it in 27 quarters. The position peaked at $1.78M in Q2 2020. 58 funds tracked by Wall St. Rank hold ADVM as of Q2 2025.
- Simplex Trading reported no remaining Adverum Biotechnologies position as of Q2 2025 after selling out during the quarter.
- Simplex Trading sold 4,313 Adverum Biotechnologies shares in Q2 2025, an estimated $12.1K.
- Simplex Trading first reported a position in Adverum Biotechnologies in Q1 2015 and held it in 27 quarters.
- Simplex Trading's Adverum Biotechnologies position peaked at $1.78M in Q2 2020.
- 58 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q2 2025.
Based on Simplex Trading's 13F filing for Q2 2025, filed 5 Aug 2025.